# LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

> **NCT06391125** · PHASE3 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 48 (estimated)

## Conditions studied

- Syphilis Infection
- Benzathine Penicillin Adverse Reaction

## Interventions

- **DRUG:** normal Saline
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT06391125
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06391125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06391125, "LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06391125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*